Skip to main content
OpenTrials
Completed

NCT Number: NCT05251467

A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF

Development of a new patient reported outcome measure (PROM) that will measure the daily burden of gastrointestinal symptoms over the previous 24 hour period for people with cystic fibrosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nottingham University Hospitals NHS Trust

Nottingham, NG7 2UH, United Kingdom

About this study

Development of a Patient Reported Outcome Measure (PROM) in line with FDA guidance. The PROM is intended for daily use to measure the symptom burden of gastrointestinal symptoms for people with CF over the last 24 hours.

  • Development of the initial conceptual framework underpinning the PROM and confirmed through a patient focus group.
  • Primary item (question) generation for the PROM which will then be refined through a series of interviews with people with CF.
  • Testing of the items through an online patient questionnaire for testing of frequency, burden and impact of the items.
  • Piloting testing of the draft PROM daily for 2 weeks via smartphone app. The recall period of the PROM will be gastrointestinal symptom burden over the previous 24 hours.

Potential participant's will be identified through 6 UK CF care centres at Nottingham University Hospitals NHS Trust (paediatric and adult CF centres), Leeds Teaching Hospital NHS Trust, Manchester University NHS Foundation trust, Royal Brompton and Harefield NHS Foundation Trust and Kings College Hospital NHS Foundation Trust. In addition, recruitment for the survey and trialing the PROM on a smartphone app will also take place via social media and is therefore also open to people with CF from outside these CF centres.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People with cystic fibrosis age 12 years and over
  • Confirmed diagnosis of cystic fibrosis based on genotype or sweat chloride testing
  • Capacity to consent, or to understand the requirements of the study where parental consent is required

Exclusion criteria

  • < 12 years age
  • Unable to give informed consent

Treatment and study plan

Focus Group

Other

Focus group to confirm PROM conceptual framework

Patient interview (n = approximately 10)

Other

Patient interviews to refine possible questions for the PROM

Questionnaire (n = 180)

Other

Online questionnaire to evaluate the proposed questions as part of PROM development in a larger population

Testing of the pilot PROM in a smartphone app (n = 150)

Device

Daily testing of the pilot PROM in a smartphone app for 2 weeks

Primary outcomes

  1. To develop a new patient reported outcome measure (PROM) which will measure the daily gastrointestinal symptom burden for people with CF, with a recall period of 24 hours.

    Time frame: 2 years

    Development of a new PROM following FDA guidance which will measure the daily impact and burden of gastrointestinal symptoms for people with CF. The recall period will be the previous 24 hours. The name of the PROM will be decided as part of the development process. Question development will be iterative. Floor and ceiling effects for each of the questions will be assessed. The CFAbd score will be used to assess construct validity of the newly developed PROM. This will be completed alongside the PROM on days 1 and day 14.

Secondary outcomes

  1. Measurement of adherence to daily data capture of the PROM through a smartphone app over a 2 week period

    Time frame: 2 years

    Adherence data - Percentage of completed PROM days over the 14 day period. Percentage of completed CFabd scores on days 1 and 14. This data will be collated through the research portal feedback facility in the app.

  2. Attrition rate of participants

    Time frame: 2 years

    Attrition rate over the 2 weeks, define as people completing the app for two weeks (at least 10 out of 14 days) as a percentage of those initially who gave consent to take part and use the app.

  3. Usability of the smartphone app

    Time frame: 2 years

    Usability of the app - participant feedback via the app on days 7 and 14 to include questions of ease of data entry on the app, whether they experience any technical issues with the app and whether questions are meaningful to participants. These questions will be developed as part of the PROM development process.

Sponsors and collaborators

Lead sponsor

Nottingham University Hospitals NHS Trust

Other

Collaborators

  • King's College Hospital NHS Trust
  • Manchester University NHS Foundation Trust
  • Medizinische Hochschule Brandenburg Theodor Fontane
  • Royal Brompton & Harefield NHS Foundation Trust
  • The Leeds Teaching Hospitals NHS Trust

Registry information

Acronym: CARDS-CF

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Feb 22, 2022
Registry last updated
Jul 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.